Predicting response to immunotherapy
Studies show progress in learning to predict which patients are most likely to respond to certain cancer treatments known as immune checkpoint therapies.
Source: NIH Research Matters from the National Institutes of Health (NIH) - Category: Consumer Health News Source Type: news
More News: Cancer | Cancer & Oncology | Health | Immunotherapy | Learning | National Institutes of Health (NIH) | Study | Universities & Medical Training